scholarly journals Case of Poliomyelitis Caused by Significantly Diverged Derivative of the Poliovirus Type 3 Vaccine Sabin Strain Circulating in the Orphanage

Viruses ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 970
Author(s):  
Ekaterina A. Korotkova ◽  
Maria A. Prostova ◽  
Anatoly P. Gmyl ◽  
Liubov I. Kozlovskaya ◽  
Tatiana P. Eremeeva ◽  
...  

Significantly divergent polioviruses (VDPV) derived from the oral poliovirus vaccine (OPV) from Sabin strains, like wild polioviruses, are capable of prolonged transmission and neuropathology. This is mainly shown for VDPV type 2. Here we describe a molecular-epidemiological investigation of a case of VDPV type 3 circulation leading to paralytic poliomyelitis in a child in an orphanage, where OPV has not been used. Samples of feces and blood serum from the patient and 52 contacts from the same orphanage were collected twice and investigated. The complete genome sequencing was performed for five polioviruses isolated from the patient and three contact children. The level of divergence of the genomes of the isolates corresponded to approximately 9–10 months of evolution. The presence of 61 common substitutions in all isolates indicated a common intermediate progenitor. The possibility of VDPV3 transmission from the excretor to susceptible recipients (unvaccinated against polio or vaccinated with inactivated poliovirus vaccine, IPV) with subsequent circulation in a closed children’s group was demonstrated. The study of the blood sera of orphanage residents at least twice vaccinated with IPV revealed the absence of neutralizing antibodies against at least two poliovirus serotypes in almost 20% of children. Therefore, a complete rejection of OPV vaccination can lead to a critical decrease in collective immunity level. The development of new poliovirus vaccines that create mucosal immunity for the adequate replacement of OPV from Sabin strains is necessary.

PEDIATRICS ◽  
1977 ◽  
Vol 60 (1) ◽  
pp. 80-82
Author(s):  
Richard D. Krugman ◽  
George E. Hardy ◽  
Clyde Sellers ◽  
Paul D. Parkman ◽  
John J. Witte ◽  
...  

Five years after primary infant immunization with trivalent oral poliovirus vaccine, employing either a three-dose primary series as recommended by the U.S. Public Health Service Advisory Committee on Immunization Practices (ACIP) or a four-dose series as recommended by the Committee on Infectious Diseases of the American Academy of Pediatrics, 115 children were serologically tested for persistence of neutralizing antibodies by the microneutralization test. Of the 57 individuals immunized according to the ACIP recommendation, antibody persistence was demonstrated in 92% for type 1 poliovirus, 98% for type 2, and 84% for type 3. Of those 58 individuals originally receiving a four-dose primary infant immunization series, the persistence of antibody was 98% to type 1, 98% to type 2, and 87% to type 3. Twenty-one of 24 negative sera showed neutralizing ability when tested by a more sensitive plaque reduction test. Thus, individuals completing either immunization schedule demonstrated satisfactory persistence of neutralizing antibody to all three poliovirus types over a five-year period.


The Lancet ◽  
1986 ◽  
Vol 327 (8495) ◽  
pp. 1427-1432 ◽  
Author(s):  
T. Hovi ◽  
A. Huovilainen ◽  
T. Kuronen ◽  
T. Pöyry ◽  
N. Salama ◽  
...  

1967 ◽  
Vol 65 (1) ◽  
pp. 77-84 ◽  
Author(s):  
Yvonne E. Cossart

Strains of poliovirus were obtained from 13 of the 18 persons in England and Wales with paralytic episodes after administration of oral vaccine in 1962. They have been studied using three marker tests: the R.C.T.40 test, intratypic serodifferentiation and inhibition by dextran sulphate. For comparison a number of strains from subjects with non-paralytic vaccine-associated reactions and from patients with paralytic poliomyelitis not related to vaccine were also tested.Of the eight patients excreting type 1 strains seven came from South Wales where an outbreak was in progress. They all resemble naturally occurring strains from the outbreak in growing at 39·3° but not at 39·8° C.Only one subject excreted type 2 virus which was of vaccine type.The type 3 strains included a series from a family group where a range of results from vaccine to the wild range was obtained. Three other patients with vaccineassociated paralysis excreted type 3 strains with the characteristic of naturally occurring strains.


1996 ◽  
Vol 38 (2) ◽  
pp. 157-161 ◽  
Author(s):  
Eliseu Alves Waldman ◽  
Regina C. Moreira ◽  
Sueli G. Saez ◽  
Denise F.C. Souza ◽  
Rita de C.C. Carmona ◽  
...  

To investigate the possible role of domestic animals as reservoirs of human enteroviruses, we studied 212 stray dogs captured in different areas of the municipality of São Paulo. The captured animals were divided into 19 groups of 10 to 20 dogs each; faeces of 126 of the 212 dogs were processed for enterovirus isolation. The following viruses were isolated from 12 dogs: poliovirus type 1 (2 dogs), poliovirus type 3 (1 dog), echovirus type 7 (8 dogs) and echovirus type 15 (1 dog). Of the 12 infected animals, four had specific homotypic neutralizing antibody titres > 16. All 212 animals were tested for the presence of neutralizing antibodies to human enteroviruses. The frequency of neutralizing antibodies present in titres of > 16 was 10.3%, 3,8% and 4.3% for vaccinal prototypes of polioviruses 1, 2 and 3 respectively; 1,9%, 1.4% and 1.5% for wild prototypes of the same viruses, 11.3% for echovirus 7, and 2.4% for echovirus 15. The proportion of dogs with neutralizing antibodies varied with the virus studied. Some indication of the susceptibility of dogs to infection with human enteroviruses was demonstrated, and the importance of this fact for the Plan for Global Eradication of the Wild Poliovirus is discussed.


1978 ◽  
Vol 80 (1) ◽  
pp. 155-167 ◽  
Author(s):  
J. W. G. Smith ◽  
P. J. Wherry

SUMMARYPoliomyelitis continued to be a rare disease in England and Wales in the period 1969–75. Only 31 paralytic and 44 cases of possible non-paralytic poliomyelitis were recorded during the 7 years.Of the 31 paralytic cases approximately one third were vaccine-associated; 3 were patients who had recently received oral poliovaccine and 7 had been in contact with a vaccinated person. Five of these 7 patients were parents of recently vaccinated children. The rate of vaccine-associated poliomyelitis was estimated in recipients to be 0·2 and in contacts 0·4 per million doses of vaccine given.Marker test results were reported on 555 strains of poliomyelitis virus isolated during 1969–75, using the reproductive capacity temperature test. Forty-eight (8·6%) resembled wild virus in this property, 15 strains being type 1, 8 type 2 and 25 type 3. Most of these isolations of apparently wild virus were from excreters with no symptoms of poliomyelitis, although 3 of the 15 type 1 strains were from patients with paralytic poliomyelitis and 3 from possible cases of non-paralytic poliomyelitis. None of the 8 apparently wild type 2 viruses was from a case of paralytic illness and only 1 of the 39 type 3 strains.Eleven of the 31 paralytic cases were in patients in whom the infection was likely to have been acquired abroad.


2003 ◽  
Vol 69 (5) ◽  
pp. 2919-2927 ◽  
Author(s):  
Jagadish M. Deshpande ◽  
Sushmitha J. Shetty ◽  
Zaeem A. Siddiqui

ABSTRACT Eradication of poliomyelitis from large metropolis cities in India has been difficult due to high population density and the presence of large urban slums. Three paralytic poliomyelitis cases were reported in Mumbai, India, in 1999 and 2000 in spite of high immunization coverage and good-quality supplementary immunization activities. We therefore established a systematic environmental surveillance study by weekly screening of sewage samples from three high-risk slum areas to detect the silent transmission of wild poliovirus. In 2001, from among the 137 sewage samples tested, wild poliovirus type 1 was isolated from 35 and wild poliovirus type 3 was isolated from 1. Acute flaccid paralysis (AFP) surveillance indicated one case of paralytic poliomyelitis from the city. Phylogenetic analysis with complete VP1 sequences revealed that the isolates from environmental samples belonged to four lineages of wild polioviruses recently isolated from poliomyelitis cases in Uttar Pradesh and not to those previously isolated from AFP cases in Mumbai. Wild poliovirus thus introduced caused one case of paralytic poliomyelitis. The virus was detected in environmental samples 3 months before. It was found that wild polioviruses introduced several times during the year circulated in Mumbai for a limited period before being eliminated. Environmental surveillance was found to be sensitive for the detection of wild poliovirus silent transmission. Nucleotide sequence analysis helped identify wild poliovirus reservoir areas.


Author(s):  
Sani Ousmane ◽  
Dan Dano Ibrahim ◽  
Ajay Goel ◽  
William S Hendley ◽  
Bernardo A Mainou ◽  
...  

Abstract Background Outbreaks of vaccine-derived poliovirus type 2 (VDPV2) continue to expand across Africa. We conducted a serological survey of polio antibodies in polio high-risk areas of Niger to assess risk of poliovirus outbreaks. Methods Children between 1 and 5 years of age were enrolled from structures randomly selected using satellite imaging enumeration in Diffa Province, Niger in July 2019. After obtaining informed consent, dried blood spot cards were collected. Neutralizing antibodies against three poliovirus serotypes were detected using microneutralization assay at the Centers for Disease Control and Prevention, Atlanta. Results We obtained analysable data from 309/322 (95.9%) enrolled children. Seroprevalence of polio antibodies was 290/309 (93.9%), 272/309 (88.0%), and 254/309 (82.2%) for serotypes 1, 2 and 3 respectively. For serotypes 1 and 2 the seroprevalence did not significantly change with age (p=0.09, p=0.44 respectively); for serotype 3 it increased with age (from 65% in 1-2 year-olds to 91.1% in 4-5-year olds; p<0.001). We did not identify any risk factors for type 2 seronegativity. Conclusions With type 2 seroprevalence close to 90%, the risk of emergence of new cVDPV2 outbreaks in Niger is low, however, the risk of cVDPV2 importations from neighbouring countries leading to local transmission persists. Niger should maintain the outbreak response readiness capacity; and further strengthen its routine immunization.


1957 ◽  
Vol 55 (2) ◽  
pp. 239-253 ◽  
Author(s):  
C. A. Evans ◽  
Velma C. Chambers ◽  
W. R. Giedt ◽  
A. N. Wilson

SUMMARY AND CONCLUSIONSIn October, November and early December 1952, an epidemic of poliomyelitis, with an attack rate exceeding 1 %, occurred in Ketchikan, Alaska, a community of approximately 6000 persons. Approximately half of the cases were paralytic.Type 1 virus was regarded as the principal cause of the epidemic because Type 1 virus was isolated from one patient, and sera from eleven of twelve paralytic patients tested were positive for neutralizing antibodies to Type 1 virus. Three patients had antibodies to Type 2 virus and eight to Type 3.Serological tests were made to determine the immune status of the general population at the time the epidemic terminated. Approximately one-third of twenty-five children from 6 months to 4 years of age had antibodies to Type 1 virus. Of the 105 children aged 5 to 9 years, approximately three-quarters were positive for antibodies to this virus. All but two of the twenty-six persons more than 9 years of age who were tested were similarly positive.Spread of Type 2 and Type 3 viruses was more limited in Ketchikan than spread of Type 1 virus. Serological evidence is presented to show that Type 3 poliomyelitis virus was present in Ketchikan some time within the 3-year-period prior to the collection of serum in December 1952. Since the proportion of children showing antibodies to Type 3 virus did not increase with age from 3 to 9 years, it is surmised that virus of this type was not prevalent for a number of years prior to its last occurrence. It is further concluded that spread of Type 3 virus must have terminated when 40 % or less of the children of pre-school age and early school age had been infected and developed antibodies.Type 2 virus apparently had not been prevalent for several years prior to December 1952. Only one of twenty-one specimens of serum from children under age 5 showed definite evidence of neutralizing antibodies and this child had resided elsewhere during the first 3 months of its life. The proportion of positive results in all ages to 9 years inclusive was well below that obtained in tests with Type 1 virus.From a review of published data concerning the age distribution of cases in the 1916 epidemic in New York, it is concluded that termination of the spread of Type 1 virus in Ketchikan occurred when the proportion of susceptibles in the general population was comparable to that in New York in each of several non-epidemic years preceding 1916. It is further evident that spread of Type 2 virus in Baltimore during a period of low prevalence of poliomyelitic disease was comparable to that of Type 1 virus in Ketchikan in 1952, in that the proportion of susceptibles in the population at the end of the period of spread of virus was similar.Serological studies of residents of Metlakatla, an Indian community near Ketchikan, showed evidence of essentially uniform infection with Type 1 virus, a very high incidence of antibodies to Type 3 virus, and a much lower incidence of antibodies to Type 2 virus.The epidemiological aspects of poliomyelitis in Ketchikan cannot be reasonably attributed to susceptibility resulting from isolation of the community, since travel to and from Ketchikan was considerable and a relatively large proportion of persons with paralytic disease were adults who had travelled extensively, and resided for periods of years in various parts of the United States. It is noted that the municipal water supply showed frequent evidence of faecal pollution.The willing co-operation and valuable assistance of the following persons is gratefully acknowledged: Mr Alfred Baker, Mrs Dixie M. Baade, Miss Geneva Hubbard and Miss Lorraine Singer of the Ketchikan office of the Alaska Territorial Health Department; and Dr C. Earl Albrecht, Director and Dr Charles R. Hayman, Chief of Section of Preventive Medical Services, of the Alaska Territorial Department of Health.The National Foundation for Infantile Paralysis financed the initial visits to Ketchikan. Testing of specimens was accomplished through the support of the University of Washington Fund for Biological and Medical Research and the Office of Naval Research.


Sign in / Sign up

Export Citation Format

Share Document